Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TLX
TLX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TLX News
Telix Pharmaceuticals Enters Phase 3 Trial for Brain Cancer Treatment
12h ago
Yahoo Finance
Telix Pharmaceuticals Doses First Patient in Phase 3 Trial for Glioblastoma Treatment
4d ago
NASDAQ.COM
Telix's TLX101-Tx Enters Phase 3 Clinical Trial for Glioblastoma
5d ago
Newsfilter
Telix Successfully Prices $600 Million Convertible Notes Offering
5d ago
Newsfilter
Telix Doses First Patient in Phase 3 IPAX BrIGHT Trial for Recurrent Glioblastoma
5d ago
Yahoo Finance
Telix Successfully Prices $600 Million Convertible Notes Offering
5d ago
PRnewswire
Telix Launches $550 Million Convertible Notes Offering
5d ago
PRnewswire
Telix Launches $550 Million Convertible Notes Offering
5d ago
Newsfilter
Regeneron and Telix Collaborate on Radiopharmaceuticals
6d ago
seekingalpha
Regeneron and Telix Collaborate on Next-Gen Radiopharmaceuticals
6d ago
Globenewswire
Regeneron and Telix Collaborate on Next-Gen Radiopharmaceuticals
6d ago
Newsfilter
Telix and Regeneron Collaborate on Next-Gen Radiopharmaceuticals
Apr 13 2026
NASDAQ.COM
Telix and Regeneron Collaborate on Radiopharmaceutical Development
Apr 12 2026
Yahoo Finance
TELIX PHARMACEUTICALS LTD SET TO RECEIVE $40 MILLION INITIAL PAYMENT AND POTENTIAL UP TO $2.1 BILLION IN MILESTONE PAYMENTS AND ROYALTIES
Apr 12 2026
moomoo
FDA Accepts Telix NDA for Pixclara Brain Cancer Imaging
Apr 10 2026
Newsfilter
Health Care Stocks Steady Pre-Bell Friday
Apr 10 2026
Yahoo Finance
Show More News
